GENE ONLINE|News &
Opinion
Blog

HIV
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Study Finds High Viral Loads Fuel Higher HIV Recombination Rates
2024-01-12
GSK Boosts HIV Drug Business Forecasts as Apretude Sales Surge
2023-10-03
New White Blood Cell Subtype as HIV Reservoir Identified
2023-04-07
Fifth HIV Patient Cured After Stem Cell Transplant in Germany
2023-03-01
Gilead Touts Long-Term Efficacy And Safety Data For HIV Drug
2022-10-26
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
A Cure for HIV Could Be Here Sooner Than You Think – Future of Health
2022-09-16
Gilead’s Novel Capsid Inhibitor Treatment for HIV Gains First Approval from European Commission
2022-08-22
HIV Latent Cells Could Lead to Possible Cure
2022-07-28
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
This One-Time Injection Could Cure AIDS
2022-06-21
FDA Allows Resumption of Gilead’s Lenacapavir AIDS Trials
2022-05-19
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
2021-12-22
1 2 3
LATEST
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
EVENT
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top